![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Undurraga Juan
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.35, Iss.12, 2012-12, pp. : 1185-1186
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sizing up olanzapine in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine is beneficial for adolescents with schizophrenia
Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. :